Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium
Playback speed
10 seconds
AUTO3 and Beyond: Experience With Co-targeting of CD19 and CD22 in DLBCL and B-ALL
22 views
September 9, 2021
Comments 0
Login to view comments.
Click here to Login
Keynote and Plenary Sessions